Corrigendum

    April 2021 in “ Journal of the European Academy of Dermatology and Venereology ”
    Image of study
    TLDR The document corrects an author's affiliation in previous articles about COVID-19 and its links to hair loss and hormones.
    This document is a corrigendum to correct the institutional affiliation of Flavio A. Cadegiani, which was previously listed incorrectly as 'Federal University of São Paulo' in four articles related to COVID-19 and its association with androgenetic alopecia, hyperandrogenism, and the use of anti-androgens. The correct affiliations should be 'Corpometria Institute, Brasilia, DF, Brazil' and 'Applied Biology Inc, Irvine, CA, USA'. The articles in question discussed the reduced frequency of COVID-19 symptoms in males with androgenetic alopecia taking 5-alpha-reductase inhibitors, the clinical symptoms of hyperandrogenic women diagnosed with COVID-19, the potential protective effects of anti-androgens against severe COVID-19 outcomes, and how an androgen receptor genetic variant may predict COVID-19 disease severity.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results

    Related Community Posts Join

    6 / 1000+ results

      community Quit vaping/smoking = 80% less loss

      in Research/Science  235 upvotes 8 months ago
      Quitting vaping significantly reduced hair loss for a user who was a heavy vaper and also taking finasteride. Some participants suggest nicotine's vasoconstrictive properties may worsen hair loss, while others share personal anecdotes of hair improvement after quitting smoking or vaping.

      community Proposed new pathogenesis model for androgenetic alopecia (AGA)

      in Research/Science  8 upvotes 1 year ago
      The conversation discusses a new model for understanding androgenetic alopecia (AGA), linking it to dietary and lifestyle factors similar to PCOS, and highlighting the role of DHT, vascular damage, and inflammation. Treatments mentioned include Minoxidil, finasteride, and RU58841.

      community Spironolactine Update: 2 months (34, Female)

      in Female  20 upvotes 7 years ago
      A female user's experience using Spironolactone to treat Female Pattern Hair Loss (FPHL) and Androgenic Alopecia, as well as discussing the effectiveness of the drug at different dosages.

      community Androgenetic alopecia is a skin disease: DHT-mediated skin disorders

      in Research/Science  65 upvotes 1 year ago
      Dihydrotestosterone (DHT) impacts various skin conditions, including Androgenetic alopecia and seborrheic dermatitis, by causing overactivity in sebaceous glands. Topical medications Tacrolimus and Clobetasol can reduce these inflammatory conditions, and treatments like RU58841, Minoxidil, and Finasteride may also be beneficial.

    Related Research

    2 / 2 results